Methicillin-resistant Staphylococcus aureus (MRSA) screening plays a great role in preventing infections in surgical patients. This study aims to evaluate clonality, virulence and resistance of MRSA in pre-and post-liver transplantation (LT) patients. Nasal and groin swabs of 190 patients were collected. PCR for virulence genes and staphylococcal cassette chromosome mec (SCCmec) types, microarray, PFGE, multilocus sequence typing and MIC were performed. MRSA carriers were detected in 20.5 % (39/190) of the patients. However, only three colonized patients developed infections post-LT. Sixty-nine MRSA isolates were identified, and the most frequent SCCmec type was type II (29/69; 42.0 %). Most isolates (57/69; 82.6 %) were susceptible to trimethoprim-sulfamethoxazole (TMP/SMX) and harboured the lukD, lukE, clf and fnbA genes as determined by PCR. Five sequence types (ST) were identified among nine clones; 36.2 % (25/69) isolates belonged to a predominant clone (ST105 and SCCmec type II) that was susceptible to TMP/SMX, mupirocin and chlorhexidine, which had 87.9 % similarity with the New York/Japan clone. The array showed virulence difference in isolates of the same clone and patients and that colonized isolates (pre-LT patients) were less virulent than those post-LT and those infected. Therefore, despite the high frequency of MRSA colonization, infection due to MRSA was uncommon in our LT unit. MRSA isolates presented great diversity. Isolates of the same clone expressed different virulence factors by array. Colonizing isolates pre-LT expressed less virulent factors than post-LT and infecting isolates.
INTRODUCTION
Staphylococcus aureus is one of the most commonly reported pathogens related to healthcare-associated infection in liver transplantation (LT) . Previous studies of healthcare-associated infection in LT patients showed methicillin-resistant S. aureus (MRSA) as the cause of bloodstream infections and its impact on morbidity and mortality (Bert et al., 2010; Romanelli et al., 2010) . A retrospective study conducted by Takatsuki et al. (2010) showed that MRSA infections had a high mortality rate in LT patients.
MRSA colonization before LT occurs in 5.1-47.4 % of the cases (Singh et al., 2006; Hashimoto et al., 2007) and can be associated with a higher risk of infection (Desai et al., 2003; Bert et al., 2005; Hashimoto et al., 2008) . According to Schlievert et al. (2010) , methicillin resistance is not a direct factor that increases virulence of S. aureus but rather indirectly influences the production of virulence factors, which clearly makes clinical management of staphylococcal infections more difficult. To facilitate virulence studies, new methods based on bacterial genome have been proposed (McNicholas et al., 2011; Li et al., 2013) . The microarray technique can be considered an important tool that allows different virulence genes to be detected and levels of gene expression to be evaluated in MRSA isolates.
Besides the occurrence of virulence factors produced by MRSA strains, the molecular characterization of these isolates in an LT unit in a tertiary-care hospital is very important to define strategies to control and prevent nosocomial infection. This characterization allows us to know if there is an antimicrobial resistance gene (like the mupirocin gene and other genes related to antimicrobials used in prophylaxis and treatment) and resistance to chlorhexidine in LT MRSA isolates. Chlorhexidine and mupirocin are widespread agents used in routine hospital cleaning, skin antisepsis and patient decolonization (Centers for Disease Control and Prevention, 2002) .
Therefore, we conducted a study to evaluate the carriage rate of MRSA and the association with infection due to this agent and to assess molecular and virulence characterization of MRSA isolates from pre-LT and post-LT patients. The aim of this study was to determine the rate of colonization of patients and the microbiological characteristics (phenotypic and genotypic) of MRSA isolates in order to propose a future intervention study in LT units of our hospital, by defining MRSA-specific control strategies for decolonization with antimicrobial agents, such as chlorhexidine baths and treatment with nasal mupirocin.
METHODS
Patients. The present study was conducted at the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, a tertiary university hospital affiliated with the University of Sao Paulo, Brazil, from August 2010 to January 2012. All patients filled out a form agreeing to participate in this study, which was approved (no. 0307/09) by the ethics committee.
In our hospital, patients were selected for the liver waiting list according to their MELD (Model for End-stage Liver Disease) score. Patients with MELD score above 25 were submitted for LT.
The analysed patient population comprised 126 pre-LT, 64 post-LT and 6 patients with clinical MRSA infection. A questionnaire was applied to pre-LT patients, and data were collected (age, sex, underlying diseases, hospitalization or any hospital procedure within the previous 6 months and previous use of antimicrobial drugs). Data from post-LT patients were also registered [surgical date, type of transplant (living/cadaveric donor or re-transplantation) and variables related to the surgery such as the American Society of Anesthesiologists (ASA) score, MELD score and ischaemia time]. Data from nosocomial infections (30 days posttransplantation) were also included (type of infections): surgical site infection (SSI), bloodstream infections, urinary tract infections, pneumonia and others. SSI was classified as superficial incisional surgical site, deep incisional surgical site and organ or space surgical site (OSSS) infections according to the Centers for Disease Control and Prevention (Garner et al., 1998) . The approximate date of infection and the bacteria isolated were also documented.
Hospital-acquired MRSA (HA-MRSA) isolates have been defined as MRSA isolated from hospitalized patients (with previous hospitalization in the previous 6 months), whereas community-acquired MRSA (CA-MRSA) isolates were obtained from patients with no hospitalization reported in the previous 6 months from data collection. A database was built using Epi Info (version 3.5.1) to describe clinical and demographic data. Previous use of antibiotic and hospitalization in the first 6 months among MRSA colonized and non-colonized cirrhotic patients was compared using the chi-squared test, and other continuous variables related to the LT surgery such as MELD score, ASA score and ischaemia time were compared using the Kruskal-Wallis test, where P<0.05 was considered significant. The following variables were evaluated: age, gender, immunosuppressive drugs, hepatic failure, MELD score, duration of surgery and ischaemia.
Samples. We collected nasal and groin swabs from 190 patients (126 pre-LT and 64 post-LT). In order to increase the culture's sensitivity, samples were collected up to 48 h after transplantation and once a week from post-LT patients (up to 1 month after the transplant surgery).
Detection of MRSA. Swab samples were cultured according to Böcher et al. (2008) . Four to five colonies were subcultured on blood agar plates, and S. aureus was identified by Gram staining, catalase, coagulase and DNase tests (Kateete et al., 2010) . Methicillin resistance (resistance to oxacillin and penicillin) was determined according to the Clinical Laboratory Standards Institute (CLSI, 2009 (CLSI, , 2014 and confirmed by PCR multiplex amplifications of coA and mecA genes (Kearns et al., 1999) . S. aureus ATCC 29213 and NCTC10442 were used as control strains.
Susceptibility testing. Susceptibility testing of MRSA isolates was performed by broth microdilution method (CLSI, 2014) to the following antibiotics: oxacillin, penicillin, clindamycin, erythromycin, vancomycin, trimethoprim-sulfamethoxazole (TMP/SMX), ciprofloxacin, gentamicin, chloramphenicol and tetracycline. D-test and susceptibility to mupirocin were performed by disk diffusion method (CLSI, 2014) . Mupirocin resistance was defined as a zone of 13 mm using a 5 µg disk (Malaviolle et al., 2008; McDanel et al., 2013) . There is no CLSI method for chlorhexidine, so the MIC was determined using the standard agar dilution technique, and S. aureus ATCC 29213 was used for quality control (McDanel et al., 2013) . by BioNumerics version 7.1 software (Applied-Maths). PFGE types and subtypes were defined by groups formed at 80 % Dice similarity cutoffs, on a dendrogram constructed by the unweighted pair group method using average linkages. For band pattern comparisons within and between different gels, optimization of 0.5 % and position tolerance of 1.5 % were used (Mulvey et al., 2001; McDougal et al., 2003) .
SCCmec types. Determination of staphylococcal cassette chromosome mec (SCCmec) types was performed using a multiplex PCR method (Oliveira & De Lencastre, 2002; Zhang et al., 2005) . The MRSA strains NCTC 10442, N315, 85/2082 , JSCS 1968 , which belong to SCCmec types I, II, III, IVa, IVb, IVc, IVd and V, respectively, were used as positive controls.
Virulence genes. Virulence genes coding specific adhesions and toxins in MRSA isolates were determined by multiplex PCR (Baba-Moussa et al., 2008) . Amplification was performed as previously described by Okuma et al. (2002) .
Microarray and real-time PCR for the tst gene. The MRSA isolates were analysed using the commercially available S. aureus Affymetrix GeneChip ® , and the microarray protocol was performed according to the manufacturer's instructions. Microarray clustering was performed using a selection of 100 probe sets with high variability (for better results). Real-time PCR or quantitative PCR (qPCR) was performed with the StepOne ® Real Time system (Applied Biosystems). Primers for the tst gene were designed as described previously by Baba-Moussa et al. (2008) . Primers for the 16S rRNA (150 bp), used as endogenous control, were designed using Primer-BLAST. Real-time PCR results were analysed using the 2 ÀDDCt method as previously described by Chini et al. (2007) .
Multilocus sequence typing. MRSA isolates were selected according to PFGE types to perform multilocus sequence typing (MLST) as previously described by Enright et al. (2000) . The sequences of seven housekeeping genes (arcC, aroE, glpF, gmk, pta, tpi and yqiL) were compared to existing sequences in the MLST database. Sequence types (ST) were assigned according to their allelic profiles.
RESULTS

Patients and MRSA colonization
The study comprised 347 clinical samples (189 nasal and 158 groin swabs) taken from 190 patients. One hundred and twenty-six outpatients with liver disease on the waiting list for LT and 64 liver-transplanted patients were evaluated, of which two were re-transplanted. 39/190) The majority of LT patients were classified as ASA3 (18/64) and ASA4 (37/64); three (4.6 %; 3/64) patients, as ASA2; and two (3.1 %; 2/64) patients, as ASA5. All livertransplanted patients had a 48 h course of ampicillin plus cefotaxime as antimicrobial prophylaxis and received tacrolimus and steroids as immunosuppressive therapy. Those who developed kidney failure had the therapy replaced by adjusted doses of tacrolimus plus mycophenolate mofetil and steroids. The use of these immunosuppressive drugs could have influence on our results. Thus, to minimize the impact of such drugs on the MRSA infections, we chose to follow up the patients enrolled in our study for a short period of hospitalization after the surgery (LT). The following variables were evaluated: age, gender, immunosuppressive drugs, hepatic failure, MELD score, duration of surgery and ischaemia. Only age was associated to MRSA colonization, and duration of surgery was a protector against colonization. The use of mycophenolate mofetil had no impact on MRSA colonization (P=0.38), and neither had factors related to the surgery such as the ASA score (P=0.23), MELD score (P=0.55) and ischaemia time (P=0.43). As for the ASA score, 80 % (12/15) of colonized patients were classified as ASA4, whereas only 55 % (25/45) of non-colonized patients had the same classification (P=0.08). In average, the MELD score was 27 points for colonized patients and 25 points for non-colonized patients (P=0.55), while the ischaemia time was 400 min for colonized patients and 407 min for non-colonized ones (P=0.43). On the other hand, the median age of 46 years among non-colonized compared to 57 years among colonized patients was significantly associated to MRSA colonization (P=0.002). Duration of surgery was a protector against colonization with a median of 510 min among noncolonized patients compared to 440 min among colonized patients (P=0.04).
A total of 69 MRSA strains were isolated, of which 63 were from colonized and 6 were from infected patients. Among the 63 strains, 68.3 % (43/63) were isolated from the nasal site and 31.7 % (20/63) were from the inguinal site. Of 40 MRSA isolates from transplant patients, 21 MRSA isolates were obtained on the first post-operative period, and 19 were obtained in later collections, including 11 isolates in the second, 4 in the third and 4 in the fourth swab collection (Table 2) .
Patients and SSI
Of the 64 post-LT analysed patients (62 first transplant and 2 re-transplant), 23.4 % (15/64) showed SSI. Thirteen (20.3 %; 13/64) patients had OSSS infection, and only one presented superficial incision surgical site infection. One patient with OSSS was a re-transplanted patient. However, none showed deep incision surgical site infection.
Among the 15 patients with SSI, only one was colonized by MRSA. This MRSA isolate was submitted to microarray analysis, and the virulence results showed high expression of toxins responsible for proteolysis of host tissues, such as aureolysin (encoded by aur gene) and enterotoxin P (superantigen encoded by sep gene). A fibrinogen-binding protein that promotes cellular adhesion onto host tissues was also detected in this isolate. In three patients with SSI, no bacterial agent was defined in microbiological cultures from the site infection samples.
Susceptibility testing
Susceptibility testing demonstrated that ciprofloxacin and clindamycin showed poor activity for MRSA isolates (Table 1) . For TMP/SMX, 82.6 % (57/69) of the isolates were susceptible. Resistant isolates for this drug were characterized as SCCmec type III. Characterization of SCCmec types showed that type II is the more prevalent SCCmec in our hospital. All these isolates were resistant to TMP/SMX and tetracycline (Table 1) . One single isolate of the SCCmec type V showed resistance to oxacillin, penicillin, erythromycin, ciprofloxacin, TMP/SMX and gentamicin. All isolates were negative for the gene erm (D-test).
Sixty-eight (98.6 %; 68/69) MRSA isolates showed MICs for chlorhexidine from 1.0 to 4.0 µg ml
À1
, and only one isolate had MIC of 8.0 µg ml
. Mupirocin resistance was observed in only 4.3 % (3/69) of the isolates obtained from different patients, one pre-LT and two post-LT. These isolates had chlorhexidine MICs of 2.0 µg ml À1 and were also resistant to clindamycin, erythromycin, gentamicin and ciprofloxacin but were susceptible to chloramphenicol (Table 1 ).
Molecular characterization: PCR, PFGE, microarray and MLST
Regarding virulence genes detected by PCR , we observed that no MRSA was positive for Panton-Valentine leukocidin, eta and etb genes. However, the lukD-lukE gene was present in most isolates. The tst gene was detected in four (5.7 %; 4/69) MRSA isolates characterized as SCCmec type I, 75 % (3/4) of which belonged to pulsed-field type (PFT) D. One of these isolates had a discordant result for the tst gene according to microarray analysis and qPCR (in which presence of the tst gene was not confirmed).
PFGE identified 16 clusters (A to P types) and 29 subtypes (Fig. 1) . A predominant clone, defined as PFT A (with A1, A2, A3, A4 and A5 subtypes), was detected in 25 (36.2 %; 25/69) isolates obtained from different patients (11 pre-LT, 12 post-LT and 2 patients with MRSA infection). PFGE analysis showed that cluster A had 87.9 % similarity to New York/Japan clone (BK2464), and PFT F was related to Brazilian endemic clone (BEC) HSJ216. All PFT A were PCR positive for lukD-lukE, fnb and clf genes, determined as virulence profile 1 (P1). In this PFT, 5 MRSA isolates were SCCmec type I (20.0 %; 5/25), 19 were type II (76.0 %; 19/25) and only 1 (4.0 %; 1/25) was type III. Different virulence profiles could be seen in distinct PFGE profiles (PFT C, D and F) (Fig. 1) . SCCmec type V was carried by only one isolate which had no virulence genes detected by the PCR.
The main virulence and resistance genes were identified among 21 MRSA isolates (representative of different SCCmec types and PFGE profiles) by DNA microarray analyses (Table 3) . These isolates were obtained from eight patients and selected according to their origin and virulence profile (tst-positive isolates). Among these eight patients, 37.5 % (3/8) showed two or three PFTs among their MRSA isolates. Only one patient (ACJ) colonized by MRSA (before and after transplantation) had the same SCCmec (type I) and PFTs for all isolates (Table 4 ).
All MRSA isolates analysed by microarray harboured coA and mecA genes. The main virulence-associated genes identified are shown in Table 4 . High expression of the toxinencoding genes lukD and lukE (leukotoxins D and E) could be detected in two of the MRSA isolates obtained from the same patient (AMB). These isolates were both SCCmec type III and belonged to the same PFT (F1). 
*Up to 48 h after LT surgery. †Once a week to 1 month after LT surgery.
Other genes involved in potential host immune disorders, spa and sbi, were highly expressed in 4.8 % (1/21) and 9.6 % (2/21) of the isolates, respectively. The cap genes were expressed at a substantial level in four colonization SCCmec type I strains (one pre-LT and three post-LT). Three colonization isolates SCCmec types I and II did not express virulence genes.
Microarray results were in concordance with MIC results. For the msrA gene, two clinical isolates showed high expression and resistance to both clindamycin and erythromycin (MICs of 32.0 µg ml À1 ). One isolate that was susceptible to TMP/SMX (MIC <0.25 µg ml
À1
) had high expression of the dfrA gene, which encodes trimethoprim resistance (Table 4) .
MRSA isolates were also clustered by microarray, and the results for 21 strains were similar to PFGE. The arrays' results showed four clusters. Interestingly, patient ACJ (shown in Table 4 ) had five MRSA isolates, and all belonged to the same cluster (Fig. 2) .
MLST results identified five STs among nine isolates with different PFTs, and ST105 was detected in 55.5 % (5/9).
The PFT A was identified as ST105, and all ST105 isolates were susceptible to vancomycin, TMP/SMX, tetracycline and mupirocin (Table 5) .
DISCUSSION
To our knowledge, this is the first prospective study that evaluated MRSA virulence and resistance in LT patients using microarray. This study demonstrated that 20.5 % (39/190) of LT patients were colonized by MRSA in our hospital. However, in contrast to the literature, MRSA infection in post-LT was not frequent and occurred only in 1.6 % (1/64) of colonized patients. Bert et al. (2005) showed that only 10.1 % of non-colonized patients develop MRSA infections compared to 87.5 % of previously colonized patients. Hospitalization in the previous 6 months and previous use of antibiotics were more frequent among cirrhotic patients colonized by MRSA, but with no statistical significance. Immunosuppressive drugs and factors related to the LT surgery had no impact on colonization, except for ASA4 patients who showed a trend to significance (P=0.08). Age was significantly associated to MRSA colonization Fig. 1 . Cluster analyses of PFGE SmaI restriction fragments of 69 MRSA isolates from pre-and post-LT patients followed by SCCmec and PCR virulence gene patterns. *The cut-off value to define the PFGE types and clusters was set at 80 % similarity. †Virulence genes detected by PCR qualitative method -profile 1 (P1), lukDE, clf, fnb positives; profile 2 (P2), tst, lukDE, clf, fnb positives; profile 3 (P3), tst, clf, fnb positives; profile 4 (P4), clf, fnb positives; profile 5 (P5), lukDE, clf positives; profile 6 (P6), only lukDE positive; profile 7 (P7), no positivity. ‡PE, pre-liver transplantation patient; PO, post-liver transplantation patient; CI, clinical isolate (patient with infection). The results of molecular characterization of MRSA isolates in our study reveal a great diversity. Five STs were identified among nine clones. Although SCCmec from I to V were identified, the isolates showed a high susceptibility to TMP/ SMX, chlorhexidine and mupirocin. Only three isolates were resistant to mupirocin. These isolates were characterized as SCCmec I and II and belonged to clones PFT E and F1. Only one isolate, SCCmec II, ST105, was resistant to chlorhexidine. We identified a predominant clone during the study period characterized as ST105, SCCmec types I and II, susceptible to TMP/SMX, mupirocin and chlorhexidine, which had 87.9 % similarity with the New York/Japan clone (BK2464). The microarray demonstrated that the clones including the predominant one displayed several virulence profiles with a non-specific pattern and that colonizing isolates pre-LT were less virulent than those post-LT and clinical isolates identified in the same patient.
Some authors suggested that patients who acquired MRSA post-transplantation had higher mortality rates than those who were colonized pre-transplantation due to some associated factors such as preexisting underlying liver disease, high MELD score and prior use of antimicrobial and immunosuppressive drugs (Kim et al., 2015) . A study performed by Santoro-Lopes et al. (2005) showed a high incidence of post-operative MRSA colonization among orthotopic LT patients carried out at the Hospital Universitario Clementino Fraga Filho (RJ, Brazil). These authors detected that 15 % of the orthotopic LT recipients acquired nasal colonization with MRSA during the first 6 months of follow-up after transplantation. They also showed that longer use of indwelling urinary catheter, post-operative bleeding at the surgical site and the use of fluoroquinolones before transplantation were associated with MRSA colonization. However, there are yet no published studies showing that MRSA colonization by virulent strains was related to the rise in LT mortality rate.
The PFGE also demonstrated the presence of 16 clusters, one of them related to BEC HSJ216. The dissemination of BEC in Brazilian hospitals has been previously described (Caiaffa-Filho et al., 2013) . BEC carrying SCCmec type III is the main nosocomial clone in Brazil. In our study, 11.6 % (8/69) of the MRSA isolates related to BEC were characterized as SCCmec type III as well.
The antimicrobial susceptibility testing showed that the predominant cluster was resistant to many drugs such as ciprofloxacin and clindamycin, but susceptible to TMP/SMX. Regarding the MLST analyses, our study identified five STs among nine PFGE types which had already been described in other Brazilian studies (Pacheco et al., 2011; de Oliveira et al., 2015) .
An association between prior nasal carriage with subsequent infections has been documented previously in post-LT and cirrhotic patients (Desai et al., 2003; Paterson et al., 2003) . In our study, only five patients (corresponding to the six MRSA clinical isolates) had MRSA infection after the liver transplant. Unfortunately, it was not possible to collect swab samples from two patients after surgery due to their clinical conditions (one died and the other was in critical clinical condition). One of these patients had four MRSA strains isolated which showed two distinct PFTs: F1 (75 %, 3/4) and D1 (25 %, 1/4). SCCmec types of these isolates were also different. PFT F1 had SCCmec type III, and PFT D1 had SCCmec type I. Although the characterization of SCCmec has been different between these PFTs, both showed several virulence genes with high expression levels determined by microarray and phenotypic resistance to multiple antimicrobials except chlorhexidine and mupirocin. In contrast with our finding, a study showed that S. aureus infections occurred more frequently among lukDE, clfB, fnb coA, sei, sem, seo, set15, set6, aur, capJ, capK, capL sea, icaA, icaD, icaB, lukD, lukE, set10, set11, set15 tst, clfB, fnb icaA, set8 capB, capC, capD, capE, capF, capG, capJ, capL, capM, capN, capO, capP, seg, sem, yent1, yent2, lukDE, clfB, fnb capJ, capB, capA, icaR, sem, seb, sen, set6, aur geh, icaB, icaC, icaD, map, lukD, lukE, hly, set8, set14, set15 tst, clfB, fnb clfB, ebpS, fnbA, sdrE, spa, sei, sbi, set6, set7, set9, set14 capC, capD, capE, capF, capG, capL, capN, capM, capO, capP, set10, set11 patients with new carriage than among patients who were carriers at the time of transplantation or non-carrier patients (Singh et al., 2006) .
DNA microarray profiling allowed the detection of antimicrobial resistance and virulence genes among different MRSA clones. The majority of the isolates analysed were Fig. 2 . Clustering of microarray performed using a selection of 100 genes with the highest variability. Regarding the resistance gene expression, only one isolate (SCCmec type IV) showed high expression of dfrA gene and no phenotypic resistance to trimethoprim. Leelaporn et al. (1996) demonstrated that trimethoprim resistance may be mediated by a dfrA gene mutation (located in the staphylococcal plasmid pSK639) and horizontal acquisition of plasmid resistance determinants (types S1, S2 and S3), encoding drug-resistant variants of DHFR (dihydrofolate reductase), reducing affinity for trimethoprim (e.g. S1DHFR, encoded by dfrA gene, and S3DHFR, encoded by dfrG gene). Thus, an explanation for a susceptible MIC profile could be a possible loss or absence of plasmids. Another two isolates were resistant to TMP/SMX and had the dfrA gene present but not expressed. It is important to emphasize that there are two other genes, named dfrB and dfrG (located on the staphylococcal chromosome), and the dfrK gene (in staphylococcal plasmid) that confer low affinity to trimethoprim. These other genes were not detected in our study but could be present in TMP/SMX-resistant isolates.
Tetracycline resistance was observed in 11 isolates, but only four were analysed by microarray. Three of these (two SCCmec type III and one type II) showed the tetM gene highly expressed. One isolate resistant to this drug showed no expression of the tetM gene. This is because tetracycline resistance can also be mediated by mutations that cause increased expression of various chromosomally encoded efflux pumps (Truong-Bolduc et al., 2005) .
In this study, HA-MRSA demonstrated high resistance to erythromycin, clindamycin and ciprofloxacin and low resistance to TMP/SMX. However, one isolate had high values of MIC (128.0 µg ml À1 ) and was characterized as SCCmec type V. Such a finding is interesting because this SCCmec is considered CA-MRSA just like SCCmec type IV (Ito et al., 2004) . The profile of TMP/SMX resistance and SCCmec characterization was in agreement with the literature, in which the main SCCmec was characterized as type III (85.7 %; 12/14).
Mupirocin has been used as a successful strategy to prevent staphylococcal infections (Kaur & Narayan, 2014) . However, in a previous study (Paterson et al., 2003) , decolonization of S. aureus nasal carriage by mupirocin did not prevent infections in LT patients. Thus, the impact of decolonization with mupirocin on prevention of MRSA infections in LT patients has not been determined yet. According to the literature, chlorhexidine resistance has not been frequently described in MRSA isolates. However, mupirocin resistance rate is increasing, especially in hospital settings. Prolonged or uncontrolled use and multiple courses of mupirocin are all associated with the development of mupirocin resistance (Upton et al., 2003; Kaur & Narayan, 2014) . In our study, although mupirocin decolonization is not recommended at our hospital, mupirocin resistance was observed in 4.3 % (3/69) of the isolates. These resistant isolates belonged to SCCmec types I and II and to PFTs E and F1 (one from a pre-LT and two from post-LT patients). We found that only one MRSA isolate exhibited high chlorhexidine MIC (8.0 µg ml
À1
) and was not resistant to mupirocin. This isolate was characterized as SCCmec type II, PFT B, ST105, and was obtained from a pre-LT patient. In contrast, in a study that included 829 MRSA isolates, all MRSA isolates had chlorhexidine MICs 4.0 µg ml À1 (McDanel et al., 2013) . Our findings showed a low rate of resistance to chlorhexidine and mupirocin among MRSA isolates in our hospital, which allows us to use the decolonization strategy with these drugs in the future. The detection of mupirocin-resistant MRSA isolates could be an important tool for warning against the potential spread of this resistance in our hospital.
This study has several limitations such as having been performed in only one Brazilian centre, and the low number of MRSA infections in the post-LT patients did not allow us to compare the virulence between colonization and infection strains.
In conclusion, despite the high frequency of MRSA colonization, infection due to MRSA was uncommon in our LT unit. MRSA isolates were highly diverse. There was a predominant clone related to New York/Japan cluster characterized as SCCmec type II susceptible to TMP/SMX, mupirocin and chlorhexidine. Resistance to mupirocin and chlorhexidine was low. However, mupirocin-resistant isolates were detected in this study, indicating that this could be a future problem in our hospital. Microarray showed that MRSA colonizing isolates (obtained from pre-LT patients) expressed less virulent factors than post-LT and clinical isolates. Some virulent isolates were resistant to four or more drugs. However, our study also found drugsusceptible isolates with virulence genes expressed. Unfortunately, we did not perform studies to demonstrate an eventual correlation between resistance and virulence among the MRSA isolates.
